3//SEC Filing
GV 2014 GP, L.L.C. 3
Accession 0000899243-18-001939
CIK 0001693664other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 6:17 PM ET
Size
16.7 KB
Accession
0000899243-18-001939
Insider Transaction Report
Form 3
GV 2014, L.P.
10% Owner
Holdings
- (indirect: By GV 2014, L.P.)
Series C Convertible Preferred Stock
→ Common Stock (607,350 underlying)
Alphabet Inc.
10% Owner
Holdings
- (indirect: By GV 2014, L.P.)
Series C Convertible Preferred Stock
→ Common Stock (607,350 underlying)
GV 2014 GP, L.L.C.
10% Owner
Holdings
- (indirect: By GV 2014, L.P.)
Series C Convertible Preferred Stock
→ Common Stock (607,350 underlying)
Footnotes (2)
- [F1]The reported security is directly held by GV 2014, L.P. GV 2014 GP, L.L.C., the general partner of GV 2014, L.P., Alphabet Holdings LLC, the sole member of GV 2014 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2014 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- [F2]The reported security is convertible into the Issuer's Common Stock on a 1-for-1 basis at any time at the holder's election and shall automatically convert into Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
Issuer
ARMO BioSciences, Inc.
CIK 0001693664
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001728736
Filing Metadata
- Form type
- 3
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 6:17 PM ET
- Size
- 16.7 KB